Diabetes Care:2型糖尿病通过极低热量饮食(VLCD)可以实现逆转

2016-05-24 MedSci MedSci原创

2型糖尿病(T2DM)一般被认为是不可逆的慢性疾病。由于非常低热量饮食(VLCD)可以为一些T2DM患者带来急性逆转至正常血糖控制,因此该研究测试了这种正常化的持久性。基本的机制被定义。患糖尿病0.5-23年的患者(n=30)持续了8周的VLCD。所有的口服药物或胰岛素都在基线被停止。继而接受等热量的饮食,研究人员为这些患者提供了维持体重的结构化,个性化方案。血糖控制,胰岛素敏感性,胰岛素分泌和肝

2型糖尿病(T2DM)一般被认为是不可逆的慢性疾病。由于非常低热量饮食(VLCD)可以为一些T2DM患者带来急性逆转至正常血糖控制,因此该研究测试了这种正常化的持久性。基本的机制被定义。


糖尿病0.5-23年的患者(n=30)持续了8周的VLCD。所有的口服药物或胰岛素都在基线被停止。继而接受等热量的饮食,研究人员为这些患者提供了维持体重的结构化,个性化方案。血糖控制,胰岛素敏感性,胰岛素分泌和肝和胰腺的脂肪含量在基线时被定量,返回到等热量饮食后的6个月后,允许初次比较反应者体重损失后和6个月时的变化。反应者被定义为返回等热量饮食后实现空腹血糖<7mmol/L。

这些反应者的体重都下降了(98.0±2.6至83.8±2.4公斤),超过6个月时(84.7±2.5千克)保持稳定。30名参与者中的12名在返回到等热量饮食后空腹血糖<7mmol/L(反应者),13名参与者在6个月后实现了该血糖值。反应者有更短的糖尿病持续时间和更高的初始空腹血浆胰岛素水平。反应者的 HbA1c水平从7.1±0.3下降到5.8±0.2%(55±4至40±2mmol/L)(P<0.001),非反应者从8.4±0.3下降到8.0±0.5%(68±3至64±5mmol/L),并且在6个月时保持不变(分别为5.9±0.2和7.8±0.3%[41±2和62±3mmol/L])。反应者通过第一阶段的胰岛素反应的回归进行了表征。

一个强大的和可持续的减肥计划在40%的对VLCD有反应的患者中实现糖尿病持续缓解至少6个月,空腹血糖水平达到<7mmol/L。T2DM是一种潜在的可逆状态。

原始出处:

Sarah Steven, Kieren G. Hollingsworth,Ahmad Al-Mrabeh,et al.Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes,Diabetes Care,2016.5.24

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1901389, encodeId=37d619013895c, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Mar 08 03:46:00 CST 2017, time=2017-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637350, encodeId=bd7b163e3504b, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Apr 29 08:46:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759684, encodeId=5a301e5968451, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Sep 01 22:46:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599487, encodeId=a20c159948e46, content=<a href='/topic/show?id=d05c262e195' target=_blank style='color:#2F92EE;'>#低热量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26271, encryptionId=d05c262e195, topicName=低热量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=929918728609, createdName=hxq78322, createdTime=Thu May 26 11:46:00 CST 2016, time=2016-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1613828, encodeId=3e50161382897, content=<a href='/topic/show?id=d87e6e25687' target=_blank style='color:#2F92EE;'>#热量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67256, encryptionId=d87e6e25687, topicName=热量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bba919440409, createdName=ms2536978994064944, createdTime=Thu May 26 11:46:00 CST 2016, time=2016-05-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1901389, encodeId=37d619013895c, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Mar 08 03:46:00 CST 2017, time=2017-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637350, encodeId=bd7b163e3504b, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Apr 29 08:46:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759684, encodeId=5a301e5968451, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Sep 01 22:46:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599487, encodeId=a20c159948e46, content=<a href='/topic/show?id=d05c262e195' target=_blank style='color:#2F92EE;'>#低热量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26271, encryptionId=d05c262e195, topicName=低热量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=929918728609, createdName=hxq78322, createdTime=Thu May 26 11:46:00 CST 2016, time=2016-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1613828, encodeId=3e50161382897, content=<a href='/topic/show?id=d87e6e25687' target=_blank style='color:#2F92EE;'>#热量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67256, encryptionId=d87e6e25687, topicName=热量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bba919440409, createdName=ms2536978994064944, createdTime=Thu May 26 11:46:00 CST 2016, time=2016-05-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1901389, encodeId=37d619013895c, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Mar 08 03:46:00 CST 2017, time=2017-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637350, encodeId=bd7b163e3504b, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Apr 29 08:46:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759684, encodeId=5a301e5968451, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Sep 01 22:46:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599487, encodeId=a20c159948e46, content=<a href='/topic/show?id=d05c262e195' target=_blank style='color:#2F92EE;'>#低热量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26271, encryptionId=d05c262e195, topicName=低热量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=929918728609, createdName=hxq78322, createdTime=Thu May 26 11:46:00 CST 2016, time=2016-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1613828, encodeId=3e50161382897, content=<a href='/topic/show?id=d87e6e25687' target=_blank style='color:#2F92EE;'>#热量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67256, encryptionId=d87e6e25687, topicName=热量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bba919440409, createdName=ms2536978994064944, createdTime=Thu May 26 11:46:00 CST 2016, time=2016-05-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1901389, encodeId=37d619013895c, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Mar 08 03:46:00 CST 2017, time=2017-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637350, encodeId=bd7b163e3504b, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Apr 29 08:46:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759684, encodeId=5a301e5968451, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Sep 01 22:46:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599487, encodeId=a20c159948e46, content=<a href='/topic/show?id=d05c262e195' target=_blank style='color:#2F92EE;'>#低热量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26271, encryptionId=d05c262e195, topicName=低热量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=929918728609, createdName=hxq78322, createdTime=Thu May 26 11:46:00 CST 2016, time=2016-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1613828, encodeId=3e50161382897, content=<a href='/topic/show?id=d87e6e25687' target=_blank style='color:#2F92EE;'>#热量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67256, encryptionId=d87e6e25687, topicName=热量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bba919440409, createdName=ms2536978994064944, createdTime=Thu May 26 11:46:00 CST 2016, time=2016-05-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1901389, encodeId=37d619013895c, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Mar 08 03:46:00 CST 2017, time=2017-03-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1637350, encodeId=bd7b163e3504b, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sat Apr 29 08:46:00 CST 2017, time=2017-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759684, encodeId=5a301e5968451, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Thu Sep 01 22:46:00 CST 2016, time=2016-09-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1599487, encodeId=a20c159948e46, content=<a href='/topic/show?id=d05c262e195' target=_blank style='color:#2F92EE;'>#低热量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=26271, encryptionId=d05c262e195, topicName=低热量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=929918728609, createdName=hxq78322, createdTime=Thu May 26 11:46:00 CST 2016, time=2016-05-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1613828, encodeId=3e50161382897, content=<a href='/topic/show?id=d87e6e25687' target=_blank style='color:#2F92EE;'>#热量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67256, encryptionId=d87e6e25687, topicName=热量)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bba919440409, createdName=ms2536978994064944, createdTime=Thu May 26 11:46:00 CST 2016, time=2016-05-26, status=1, ipAttribution=)]

相关资讯

J Diabetes Investig:保护2型糖尿病,葡萄酒似乎好于啤酒和白酒

以前的荟萃分析发现,总酒精摄入量与2型糖尿病的风险见存在一定联系。研究者进行了一项荟萃分析,进一步探究不同酒精饮料与2型糖尿病发生率之间的联系。通过检索PubMed、Embase和Cochrane等数据库,识别1966-2016年2月间评估了特定酒精饮料类型与2型糖尿病风险见得前瞻性研究,使用随机或固定效应模型,计算不同酒精饮料的合并2型糖尿病相对风险(RR)和95%置信区间。这项荟萃分析包括13

Cell Metabolism:褪黑素水平的升高可增加2型糖尿病的发生风险

Cell Metabolism:褪黑素的水平升高可增加2型糖尿病的发生风险来自瑞典隆德大学的一项研究发现表明,睡眠激素褪黑素水平的增加可降低胰岛素细胞分泌胰岛素的能力。此外,他们还发现这种关联在携带与2型糖尿病发生相关的某种特定基因突变的人群中更为明显。该研究成果已在线发表于Cell Metabolism。早在2009年隆德大学的研究人员就已发现编码褪黑激素受体1B(MTNR1B)蛋白的基因突变可

Diabetes Care:自闭症谱系障碍(ASD)患者2型糖尿病的风险增加

研究表明自闭症谱系障碍(ASD)和2型糖尿病(DM)之间相关的风险因素有肥胖和血脂异常。然而,ASD和2型糖尿病之间的关联仍是未知。来自中国台湾的研究人员使用了台湾全民健康保险研究数据库,该数据库在2002年至2009年招募了6122名ASD青少年和年轻成人患者,以及24488名年龄和性别匹配的对照参与者,监测直到2011年。在随访过程中研究人员对患有2型糖尿病的患者进行了鉴定。对人口统计学数据,

Diabetes Care:2型糖尿病患者使用DPP-4与心衰入院没有联系

该研究的目的是检查在2型糖尿病患者中,心脏衰竭入院(hHF)和使用二肽基肽4抑制剂(DPP-4) vs 磺酰脲类(SUs)治疗,以及通过沙格列汀 vs 西格列汀治疗之间的关系。这项回顾性,观察性研究使用的是美国的保险索赔数据库。参与者为在2010年1月1日和2013年8月30日期间初始治疗的患者,并在过去12个月(基线)中没有使用比较治疗的方法。每个比较包括了在倾向评分中1:1匹配的患者。到每个结

Lancet Diabetes Endo:发生微血管病变的2型糖尿病患者发生心血管病风险增加

背景糖尿病使民众患心血管疾病的风险翻倍,然而预测个民众的个体风险仍然具有挑战性。糖尿病患者出现的微血管病变对其患心血管疾病的风险尚无人知晓。 方法 该研究是以人群为基础的队列研究,参与者为参与CPRD研究中的2型糖尿病患者(n = 49027)。研究人员使用多变量Cox模型来计算参与者发生主要结果(指既往没有心血管病史的患者因视网膜病变、肾脏病变、周围神经病变等多重出现心血管病性死亡、非致死性心肌

Cell Reports:利用肠道激素酪酪肽或可有效治疗2型糖尿病

Cell Reports:利用肠道激素酪酪肽或可有效治疗2型糖尿病据发表于Cell Reports 的一项新的研究表明,可抑制食欲的一种肠道激素——酪酪肽(PYY),还可影响胰岛的功能,从而或为2型糖尿病的治疗提供新的有效治疗方法。“许多病态肥胖的患者同时也是2型糖尿病患者,” Magnus Kringstad Olsen,来自挪威科学技术大学癌症研究和分子医学系,在新闻发布会上说道。肥胖患者接受